New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

ARKGvsBBPETF Comparison

ETF 1
ARKG

ARK Genomic Revolution ETF

This fund is part of
BioTech & Genomics
+0.42%
Full ARKG fund page
VS
ETF 2
BBP

Virtus LifeSci Biotech Products ETF

This fund is part of
Tomorrow's Treatments
-0.52%
Full BBP fund page

ARK Genomic Revolution ETF (ARKG) belongs to the BioTech & Genomics segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. ARKG's top 3 sector exposures are Health Care and Information Technology. In contrast, BBP's top sector exposures are Health Care  ARKG is less expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.79% for BBP. ARKG is down -9.75% year-to-date (YTD) with -$22M in YTD flows. BBP performs better with 2.1% YTD performance, and +$4M in YTD flows. Run a side-by-side ETF comparison of ARKG and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

ARKG vs BBP performance and flow charts

Performance

-50510%Feb 12Feb 20Feb 27Mar 6Mar 13

Cumulative Flows

-100 M-50 M0 MFeb 12Feb 20Feb 27Mar 6Mar 13

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/13/2026
1M3MYTD1Y3Y5Y
Perf.
ARKG
BBP
-7.14%+0.58%
-11.85%+3.36%
-9.75%+2.10%
+19.69%+35.25%
-7.59%+67.03%
-71.74%+48.61%
Flows
ARKG
BBP
-$116M+$4M
-$77M+$16M
-$22M+$4M
-$189M+$19M
-$639M+$19M
-$2.98B+$9M
Volatility and drawdown
3M1Y3Y5Y
Volatility
ARKG
BBP
+40.48%+25.64%
+44.71%+25.72%
+42.32%+23.44%
+45.24%+26.15%
Max drawdown
ARKG
BBP
-23.49%-7.42%
-23.94%-17.97%
-51.98%-25.54%
-80.33%-38.24%
Max drawdown duration
ARKG
BBP
50d32d
77d106d
968d292d
1824d915d
Trading data

Create an account to view trading data

Join for free
ARKG
BBP
Last sale
3/16/2026 at 1:30 PM
$26.55
$82.46
Previous close
03/13/2026
$26.36
$81.25
Consolidated volume
03/13/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

ARKG
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
ARKG
BBP
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/16/2026 at 1:30 PM
Live
Closed
ARKG
BBP
Last price
$26.55
$82.46
1D performance
+0.72%
+1.49%
AuM$1.04 B$48.86 M
E/R0.75%0.79%
Characteristics
ARKG
BBP
Management strategyActivePassive
ProviderArk InvestmentVIRTUS Investment Partners
Benchmark-LifeSci Biotechnology Products Index
N° of holdings3058
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateApril 2, 2019December 16, 2014
ESGNoNo
Advertisement
Exposure

Countries

ARKG
USA
73.95%
Switzerland
8.01%
Other
18.04%
BBP
USA
90.82%
Other
9.18%

Sectors

ARKG
Health Care
80.46%
Other
19.54%
BBP
Health Care
88.88%
Other
11.12%
Advertisement

Diversification

ARKG

Total weight of top 15 holdings out of 15

63.79%
BBP

Total weight of top 15 holdings out of 15

30.11%

Top 15 holdings

Data as of January 31, 2026
ARKG
CRISPR THERAPEUTICS
8.01%
PERSONALIS INC
6.15%
GUARDANT HEALTH INC
6.00%
10X GENOMICS INC
5.23%
BEAM THERAPEUTICS
4.81%
ILLUMINA
4.53%
NATERA
4.31%
RECURSION PHARMACEUTICALS
4.01%
CAREDX INC/D
3.44%
VERACYTE INC/D
3.29%
ADAPTIVE BIOTECHNOLOGIES
3.13%
INTELLIA THERAPEUTICS INC
3.10%
ABSCI
2.83%
IONIS PHARMACEUTICALS INC
2.62%
SCHRODINGER
2.33%
BBP
DAY ONE BIOPHARMACEUTICALS
2.39%
DYNAVAX TECHNOLOGIES
2.39%
AMICUS THERAPEUTICS
2.25%
IOVANCE BIOTHERAPEUTICS INC
2.18%
ARDELYX
2.09%
AXSOME THERA CMN STK
2.07%
BIONTECH SE ADR
2.07%
GILEAD SCIENCES
1.90%
KRYSTAL BIOTECH INC
1.89%
HALOZYME THERAPEUTICS
1.86%
US52635N1037
1.85%
AMGEN-T
1.83%
THERAVANCE BIOPHARMA
1.80%
INCYTE
1.78%
EXELIXIS
1.77%
Frequently asked questions about ARKG and BBP

How have the ARKG and BBP ETFs performed in 2026?

As of March 13, 2026, ARKG is down -9.75% year-to-date (YTD), while BBP has returned 2.1%. That puts BBP better performer ahead so far this year.

Which ETF is attracting more investor money: ARKG or BBP?

Year-to-date, the ARKG ETF saw -$22M in flows, compared to +$4M for BBP.

Which ETF is more volatile: ARKG or BBP?

Over the past year, ARKG had a volatility of 44.71%, while BBP experienced 25.72%.

Which ETF is bigger: ARKG or BBP?

As of March 13, 2026, ARKG holds $1.04 B in assets under management (AUM), while BBP manages $48.86 M.

What sectors do the ARKG and BBP ETFs invest in?

ARKG leans toward sectors like Health Care. Meanwhile, BBP focuses on Health Care.

What are the top holdings of the ARKG ETF and BBP ETF?

ARKG top holdings include CRISPR THERAPEUTICS, PERSONALIS INC and GUARDANT HEALTH INC. BBP holds in its top three: DAY ONE BIOPHARMACEUTICALS, DYNAVAX TECHNOLOGIES and AMICUS THERAPEUTICS.

Which ETF is more diversified: ARKG or BBP?

ARKG holds 30 securities with 63.79% of its assets in the top 15. BBP has 63 securities and a top 15 weight of 30.11%.

Advertisement
Latest news about ARKG & BBP
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up